September 14, 2020 Press release - Non-regulatory Targovax is invited to present at H.C. Wainwright 22[nd] Annual Global Investment Conference
September 2, 2020 Press release - Non-regulatory Targovax is invited to present at Pareto Nordic Healthcare conference and RAS-targeted drug development summit
August 12, 2020 Press release - Non-regulatory Targovax ASA: Invitation to presentation of Targovax’s second quarter and first half 2020 results, Thursday 20 August
June 29, 2020 Press release - Non-regulatory Targovax and Oblique enter collaboration to target mutant RAS cancers by combining their ONCOS and Abiprot™ platforms
June 24, 2020 Press release - Non-regulatory Targovax announces presentation of pre-clinical data from Next Generation ONCOS at AACR Virtual Annual Conference
June 23, 2020 Press release - Non-regulatory Targovax announces collaboration to evaluate ONCOS-102 in combination with KEYTRUDA® in mesothelioma
June 22, 2020 Press release - Non-regulatory Targovax to present at the upcoming 2020 Virtual European Biotech Investor Day 2020
June 22, 2020 Press release - Non-regulatory Targovax’s ONCOS-102 mesothelioma 12-month data powerfully demonstrate broad immune activation linked to clinical benefit
June 4, 2020 Press release - Non-regulatory Targovax enters collaboration with Leidos to add checkpoint inhibitor functionality to ONCOS viruses
May 14, 2020 Press release - Non-regulatory Targovax announces that the ONCOS-102 and durvalumab abstract is selected for a Poster Discussion Session at ASCO
May 6, 2020 Press release - Non-regulatory Targovax announces that abstract on interim phase I clinical data from the phase I/II peritoneal trial is accepted at ASCO
May 4, 2020 Press release - Non-regulatory Targovax releases update for mesothelioma trial combining ONCOS-102 and chemotherapy
April 30, 2020 Press release - Non-regulatory Targovax ASA appoints Dr Victor Levitsky as Chief Scientific Officer
April 29, 2020 Press release - Non-regulatory Targovax ASA: Invitation to online presentation of Targovax’s first quarter 2020 results, Thursday 7 May
April 22, 2020 Press release - Non-regulatory Targovax and Valo Therapeutics enter collaboration to develop RAS neoantigen coating of ONCOS viruses using PeptiCRAd technology
April 3, 2020 Press release - Non-regulatory Targovax ASA announces proposed new Chairman of the Board
March 26, 2020 Press release - Non-regulatory Targovax to present at the 2020 Solebury Trout Virtual Investor Conference today
March 20, 2020 Press release - Non-regulatory Impact of corona virus (COVID-19) on Targovax’s operations
March 3, 2020 Press release - Non-regulatory Targovax announces completed enrollment in the ONCOS-102 trial in anti-PD1 refractory melanoma
March 3, 2020 Press release - Non-regulatory Targovax ASA: Invitation to presentation of Targovax’s fourth quarter 2019 results, Wednesday 11 March
January 21, 2020 Press release - Non-regulatory Targovax announces encouraging data in mesothelioma study combining ONCOS-102 and standard of care chemotherapy
January 8, 2020 Press release - Non-regulatory Targovax and IOVaxis Therapeutics enters Option Agreement for TG mutant RAS vaccine license and clinical development in China
